Gene Therapy in Ophthalmology

Gene therapy in ophthalmology represents a cutting-edge approach aimed at treating inherited and acquired eye diseases at the genetic level. This innovative technique involves delivering therapeutic genes into target cells of the eye using viral vectors or other delivery systems. By correcting genetic mutations or introducing beneficial genes, gene therapy holds promise for conditions such as retinal dystrophies, inherited retinal diseases, and even some forms of glaucoma. Clinical trials have shown encouraging results, with potential benefits including improved visual function and slowed disease progression. Ongoing research focuses on optimizing delivery methods, enhancing safety profiles, and expanding treatment options for a broader range of ocular disorders.

    Related Conference of Gene Therapy in Ophthalmology

    December 03-04, 2026

    9th International Eye and Vision Congress

    Madrid, Spain
    March 25-26, 2027

    41st European Ophthalmology Congress

    Paris, France
    April 12-13, 2027

    26th Global Ophthalmologists Annual Meeting

    Dubai, UAE
    April 28-29, 2027

    4th International Conference on Ophthalmology

    Paris, France

    Gene Therapy in Ophthalmology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in